Ignite Creation Date:
2024-05-06 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05722015
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-28
First Post:
2023-01-27
Brief Title:
A Study of Subcutaneous SC Pembrolizumab Coformulated With Hyaluronidase MK-3475A vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer NSCLC MK-3475A-D77
Sponsor:
Organization:
Merck Sharp Dohme LLC